Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. Midatech Pharma plc
  6. Company
    MTPH   GB00BKT14T00

MIDATECH PHARMA PLC

(MTPH)
  Report
SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensus 
Business Summary
Logo Midatech Pharma plc
Midatech Pharma PLC is a research and development biopharmaceutical company that is focused on commercializing and developing products in oncology and other therapeutic areas. The Company operates through Pipeline Research and Development segment. The Pipeline Research and Development segment seeks to develop products using the nanomedicine and sustained release technology platforms. The Company develops chemo therapeutics or new immune therapeutics, using its drug delivery technologies. Q-Sphera platform is the polymer microsphere technology is used for sustained release at the microscale to prolong and control the release of therapeutics over an extended period of time from weeks to months. Midasolve platform is its nanosaccharide technology is used to dissolve drugs at the nanoscale so that they can be administered in liquid form directly and locally into tumours. Midacore platform is the gold nanoparticle technology that is used for targeting sites of disease at the nanoscale.

Number of employees : 18 people.
Sales per Business
20192020Delta
Pipeline Research and Development0.31100%0.18100% -42.31%
GBP in Million
Sales per region
20192020Delta
Rest of Europe0.0617.6%0.1163.3% +107.27%
Rest of the World0.0619.2%0.0634.4% +3.33%
United Kingdom0.2063.1%0.002.2% -97.97%
GBP in Million
Managers
Name Title Age Since
Stephen Anthony Stamp Director, Chief Executive & Financial Officer 58 2020
Steve Damment, Dr. Executive Vice President-Research & Development - 2018
Dmitry Zamoryakhin, Dr. Chief Scientific Officer - 2021
Rolf Stahel Non-Executive Chairman 75 2014
Sijmen de Vries, Dr. Independent Non-Executive Director 61 2014
Simon Turton, Dr. Senior Independent Non-Executive Director 52 2014
Fiona Sharp Group Financial Controller - -
Members of the board
Name Title Age Since
Rolf Stahel Non-Executive Chairman 75 2014
Sijmen de Vries, Dr. Independent Non-Executive Director 61 2014
Simon Turton, Dr. Senior Independent Non-Executive Director 52 2014
Stephen Anthony Stamp Director, Chief Executive & Financial Officer 58 2020
Sam Barker, Dr. Director-Business Development - 2020
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 98,468,387 85,748,721 87.1% 0 0.0% 87.1%
Shareholders
NameEquities%
Kong Lam 15,584,415 15.8%
Lombard Odier Asset Management (Europe) Ltd. 5,879,059 5.97%
China Medical System Holdings Limited 5,194,805 5.28%
Link Fund Solutions Ltd. 3,891,285 3.95%
Hargreaves Lansdown Stockbrokers Ltd. 1,514,000 1.54%
ISPartners Investment Solutions AG 1,000,000 1.02%
Jarvis Investment Management Ltd. 641,000 0.65%
Wings Establishment 518,331 0.53%
Hargreaves Lansdown Asset Management Ltd. 499,000 0.51%
IG Markets Ltd. 417,000 0.42%
Brand Portfolio
In partnership withAllbrands.markets
More brands of Midatech Pharma plc
Connections : Midatech Pharma plc